cjc 1295 ipamorelin vs aod 9604 AOD-9604 MOTS-c vs Tesamorelin vs Semaglutide vs Tirzepatide CJC-1295 No DAC & Ipamorelin

Rather than replacing growth hormone, this protocol works by stimulating the pituitary gland to produce GH in a physiologic, pulsatile manner

typically resolves within 1-2 weeks of starting therapy Headaches during early sermorelin use likely relate to changes in growth hormone signaling and associated effects on fluid balance, blood flow, and intracranial pressure regulation

Without these pillars, fat loss results may be slower or inconsistent

We assess hormone levels, metabolic markers, and lifestyle factors to determine if peptide therapy is appropriate

Misuse or incorrect dosing can cause side effects or disrupt hormone balance